Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors

Maja de Jonge, Ate van der Gaast, AST Planting, L van Doorn, ALI Boot, J Wanders, M Satomi, Jaap Verweij

Research output: Contribution to journalArticleAcademicpeer-review

61 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)3806-3813
Number of pages8
JournalClinical Cancer Research
Issue number10
Publication statusPublished - 2005

Research programs

  • EMC MM-03-86-08

Cite this